Literature DB >> 19588468

Association and gene-gene interaction of SLC6A4 and ITGB3 in autism.

D Q Ma1, R Rabionet2, I Konidari1, J Jaworski1, H N Cukier1, H H Wright3, R K Abramson3, J R Gilbert1, M L Cuccaro1, M A Pericak-Vance1, E R Martin1.   

Abstract

Autism is a heritable neurodevelopmental disorder with substantial genetic heterogeneity. Studies point to possible links between autism and two serotonin related genes: SLC6A4 and ITGB3 with a sex-specific genetic effect and interaction between the genes. Despite positive findings, inconsistent results have complicated interpretation. This study seeks to validate and clarify previous findings in an independent dataset taking into account sex, family-history (FH) and gene-gene effects. Family-based association analysis was performed within each gene. Gene-gene interactions were tested using extended multifactor dimensionality reduction (EMDR) and MDR-phenomics (MDR-P) using sex of affecteds and FH as covariates. No significant associations with individual SNPs were found in the datasets stratified by sex, but associations did emerge when we stratified by family history. While not significant in the overall dataset, nominally significant association was identified at RS2066713 (P = 0.006) within SLC6A4 in family-history negative (FH-) families, at RS2066713 (P = 0.038) in family-history positive (FH+) families but with the opposite risk allele as in the FH- families. For ITGB3, nominally significant association was identified at RS3809865 overall (P = 0.040) and within FH+ families (P = 0.031). However, none of the associations survived the multiple testing correction. MDR-P confirmed gene-gene effects using sex of affecteds (P = 0.023) and family history (P = 0.014, survived the multiple testing corrections) as covariates. Our results indicate the extensive heterogeneity within these two genes among families. The potential interaction between SLC6A4 and ITGB3 may be clarified using family history as an indicator of genetic architecture, illustrating the importance of covariates as markers of heterogeneity in genetic analyses. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19588468      PMCID: PMC3735126          DOI: 10.1002/ajmg.b.31003

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  57 in total

Review 1.  Genetics of autism: complex aetiology for a heterogeneous disorder.

Authors:  S E Folstein; B Rosen-Sheidley
Journal:  Nat Rev Genet       Date:  2001-12       Impact factor: 53.242

2.  Are rare variants responsible for susceptibility to complex diseases?

Authors:  J K Pritchard
Journal:  Am J Hum Genet       Date:  2001-06-12       Impact factor: 11.025

3.  Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions.

Authors:  Lance W Hahn; Marylyn D Ritchie; Jason H Moore
Journal:  Bioinformatics       Date:  2003-02-12       Impact factor: 6.937

4.  An autosomal genomic screen for autism.

Authors: 
Journal:  Am J Med Genet       Date:  2001-12-08

Review 5.  The genetics of autism.

Authors:  M Lauritsen; H Ewald
Journal:  Acta Psychiatr Scand       Date:  2001-06       Impact factor: 6.392

6.  A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p.

Authors: 
Journal:  Am J Hum Genet       Date:  2001-07-30       Impact factor: 11.025

7.  Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder.

Authors:  S-J Kim; N Cox; R Courchesne; C Lord; C Corsello; N Akshoomoff; S Guter; B L Leventhal; E Courchesne; E H Cook
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

Review 8.  Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review.

Authors:  Meera Vaswani; Farzana Kadar Linda; Subramanyam Ramesh
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-02       Impact factor: 5.067

9.  Serotonin transporter gene promoter variants do not explain the hyperserotoninemia in autistic children.

Authors:  A M Persico; T Pascucci; S Puglisi-Allegra; R Militerni; C Bravaccio; C Schneider; R Melmed; S Trillo; F Montecchi; M Palermo; D Rabinowitz; K-L Reichelt; M Conciatori; R Marino; F Keller
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

10.  A genomewide screen for autism susceptibility loci.

Authors:  J Liu; D R Nyholt; P Magnussen; E Parano; P Pavone; D Geschwind; C Lord; P Iversen; J Hoh; J Ott; T C Gilliam
Journal:  Am J Hum Genet       Date:  2001-07-10       Impact factor: 11.025

View more
  23 in total

1.  A literature search tool for intelligent extraction of disease-associated genes.

Authors:  Jae-Yoon Jung; Todd F DeLuca; Tristan H Nelson; Dennis P Wall
Journal:  J Am Med Inform Assoc       Date:  2013-09-02       Impact factor: 4.497

Review 2.  Modeling of Autism Using Organoid Technology.

Authors:  Hwan Choi; Juhyun Song; Guiyeon Park; Jongpil Kim
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

3.  The Gain-of-Function Integrin β3 Pro33 Variant Alters the Serotonin System in the Mouse Brain.

Authors:  Michael R Dohn; Christopher G Kooker; Lisa Bastarache; Tammy Jessen; Capria Rinaldi; Seth Varney; Matthew D Mazalouskas; Hope Pan; Kendra H Oliver; Digna R Velez Edwards; James S Sutcliffe; Joshua C Denny; Ana M D Carneiro
Journal:  J Neurosci       Date:  2017-10-16       Impact factor: 6.167

Review 4.  Neuroimaging endophenotypes in animal models of autism spectrum disorders: lost or found in translation?

Authors:  Marija M Petrinovic; Basil Künnecke
Journal:  Psychopharmacology (Berl)       Date:  2013-07-14       Impact factor: 4.530

5.  Absence of preference for social novelty and increased grooming in integrin β3 knockout mice: initial studies and future directions.

Authors:  Michelle D Carter; Charisma R Shah; Christopher L Muller; Jacqueline N Crawley; Ana M D Carneiro; Jeremy Veenstra-VanderWeele
Journal:  Autism Res       Date:  2011-01-19       Impact factor: 5.216

6.  Model-based multifactor dimensionality reduction for detecting epistasis in case-control data in the presence of noise.

Authors:  Tom Cattaert; M Luz Calle; Scott M Dudek; Jestinah M Mahachie John; François Van Lishout; Victor Urrea; Marylyn D Ritchie; Kristel Van Steen
Journal:  Ann Hum Genet       Date:  2010-09-08       Impact factor: 1.670

7.  Protocadherin α (PCDHA) as a novel susceptibility gene for autism.

Authors:  Ayyappan Anitha; Ismail Thanseem; Kazuhiko Nakamura; Kazuo Yamada; Yoshimi Iwayama; Tomoko Toyota; Yasuhide Iwata; Katsuaki Suzuki; Toshiro Sugiyama; Masatsugu Tsujii; Takeo Yoshikawa; Norio Mori
Journal:  J Psychiatry Neurosci       Date:  2013-05       Impact factor: 6.186

8.  Analysis of gene-gene interactions using gene-trait similarity regression.

Authors:  Xin Wang; Michael P Epstein; Jung-Ying Tzeng
Journal:  Hum Hered       Date:  2014-06-21       Impact factor: 0.444

9.  Association and interaction analysis of variants in CHRNA5/CHRNA3/CHRNB4 gene cluster with nicotine dependence in African and European Americans.

Authors:  Ming D Li; Qing Xu; Xiang-Yang Lou; Thomas J Payne; Tianhua Niu; Jennie Z Ma
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-04-05       Impact factor: 3.568

10.  Association and interaction analyses of 5-HT3 receptor and serotonin transporter genes with alcohol, cocaine, and nicotine dependence using the SAGE data.

Authors:  Jiekun Yang; Ming D Li
Journal:  Hum Genet       Date:  2014-03-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.